Læknablaðið - 15.11.1999, Síða 20

872
LÆKNABLAÐIÐ 1999; 85
18. Starfsreglur Leitarstöðvar Krabbameinsfélagsins. Lækna-
blaðið 1997; 83: 604-8.
19. Sigurdsson K. Quality assurance in cervical cancer screen-
ing: the Icelandic experience 1964-1993. Eur J Cancer
1995; 31A: 728-34.
20. Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson
J, Salvarsdottir A. Screening as a prognostic factor in cervi-
cal cancer: analysis of survival and prognostic factors based
on Icelandic population data, 1964-1988. Gynecol Oncol
1991;43:64-70.
21. Gardner MJ, Altman DG. Calculating confídence intervals
for proportions and their differences. In: Gardner MJ,
Altman DG, eds. Statistics with confidence. Br Med J;
1989: 28-30.
22. Disaia PJ, Morrow DP, Townsend DE. Staging and classifi-
cation. In: Quilligan EJ, ed. Synopsis of gynecologic onco-
logy. New York: Wiley; 1975: 2-5.
23. Poulsen HE, Taylor CW, Sobin LH. Histological classifi-
cation of female genital tract tumours. In: WHO internatio-
nal histological classification of tumours. Geneva: WHO;
1975: 25-6.
24. Magnus K, Langmark F, Andersen A. Mass screening for
cervical cancer in 0stfold county of Norway 1959-1977. Int
JCancer 1987;39:311-6.
25. Björge T, Gunbj0rud AB, Langmark F, Skare GB, Thoresen
S0. Cervical mass screening in Norway - 510,000 smears a
year. Cancer Detect Prev 1994; 18: 463-70.
26. Lynge E, Arffmann E, Behnfeld L, Byrjalsen C, Glenth0j A,
H0lund B, et al. Forebyggende unders0gelser mod liv-
moderhalskræft i Danmark. Status i 1995. Planer for 1996.
Ugeskr Læger 1996; 158: 4916-9.
27. Láára E, Day NE, Hakama M. Trends in mortality from
cervical cancer in the Nordic countries: association with
organized screening programmes. Lancet 1987; I: 1247-9.
28. Sigurdsson K. Effect of organized screening on the risk of
cervical cancer. Evaluation of screening activity in Iceland,
1964-1991. Int J Cancer 1993; 54: 563-70.
29. Hakama M, Louhivuori K. A screening programme for
cervical cancer that worked. Cancer Surv 1988; 7: 403-16.
30. Hakama M, Magnus K, Pettersson F, Storm H, Tulinius H.
Eífect of organized screening on the risk of cervical cancer
in the Nordic countries. In: Miller AB, Chamberlain J, Day
NE, Hakama M, Prorok PC, eds. Cancer screening. Pub-
lished for UICC, Geneva. Cambridge: Cambridge Univer-
sity Press; 1991: 153-62.
31. Forsmo S, Buhaug H, Skjeldestad FE, Haugen OA. Treat-
ment of pre-invasive conditions during opportunistic
screening and its effectiveness on cervical cancer incidence
in one Norwegian county. Int J Cancer 1997; 71: 4-8.
32. Chamberlain J. Reasons that some screening programmes
fail to control cervical cancer. In: Hakama M, Miller AB,
Day NE, eds. Screening for cancer fo the uterine cervix.
IARCSci Publ 1986; 76: 161-8.
33. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios
XM, Parkin DM. Intemational trends in the incidence of
cervical cancer: I. Adenocarcinoma and adenosquamous
cell carcinomas. Int J Cancer 1998; 75: 536-45.
34. Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell
AH, Jones WB, et al. Is there really a difference in survival
of women with squamous cell carcinoma, adenocarcinoma,
and adenosquamous cell carcinoma of the cervix? Cancer
1995; 76: 1948-55.
35. Schwartz SM, Weiss NS. Increased incidence of adenocar-
cinoma of the cervix in young women in the Unitet States.
Am J Epidemiol 1986; 124: 1045-7.
36. Geirsson G, Johannesson G, Tulinius H. Tumours in Ice-
land. 5. Malignant tumours of the cervix uteri. Histological
types, clinical stages and effect of mass screening. Acta
Path Microbiol Immunol Scand A 1982; 90: 139-43.
37. Gustafsson L, Pontén J, Bergström R, Adami H-O. Inter-
national incidence rates of invasive cervical cancer before
cytological screening. Int J Cancer 1997; 71: 159-65.
38. Sigurdsson, K. The Icelandic and Nordic cervical screening
programmes: trends in incidence and mortality rates
through 1995. Acta Obstet Gynecol Scand 1999; 78: 478-
85.
39. Hakulinen T, Andersen A, Malker B, Pukkala E, Schou G,
Tulinius H. Trends in cancer incidence in the Nordic
countries. Acta Pathol Microbiol Immunol Scand Sect A
1986; 94/Suppl. 288: 1-151.
40. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener
HC. The case for stopping cervical screening at age 50. Br J
Obstet Gynaecol 1997; 104: 586-9.
41. Sigurdsson K. Trends in cervical intra-epithelial neoplasia
in Iceland through 1995: Evaluation of targeted age groups
and screening intervals. Acta Obstet Gynecol Scand 1999;
78: 486-492.
42. Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P,
Hakama M. Effect of organised screening on cervical can-
cer incidence and mortality in Finland, 1963-1995: recent
increase in cervical cancer incidence. Int J Cancer 1999; 83:
59-65.
Fræðigreinar íslenskra lækna í erlendum tímaritum
Getið er fræðigreina. Sendið heiti greinar,
nöfn höfunda og birtingarstað til Lækna-
blaðsins. Miðað er við greinar sem birst hafa
á yfirstandandi og síðasta ári. Til
glöggvunar verður íslenskra höfunda getið
nieð fornafni þótt þess sé ekki getið við
birtingu.
* Luhr OR, Antonsen K, Magnús Karlsson,
Aardal S, Aðalbjörn Þorsteinsson, Frostell
CG, et al. Incidence and Mortality after Acute
Respiratory Failure and Acute Respiratory
Distress Syndrome in Sweden, Denmark and
Iceland. Am J Respir Crit Care Med, 1999;
159: 1849-61.
* Helga Hannesdóttir. Child and adoles-
cent psychiatry in Iceland. In: Remschmidt H,
van Engeland H, eds. Child and Adolescent
Psychiatry in Europe. Darmstadt: Springer;
1999.